nti_article_03

Nanotechnology Commercialization Group

Many of the nanotechnology inventions submitted to the Nanocommercialization Group (NCG) may be at too early a stage for licensing or investment consideration.

With that in mind, the Program to Support Translational Research (PSTR) fund provides financial support to characterize, advance the development, demonstrate the commercial potential of, or otherwise increase the commercial value of such inventions.
To be considered for funding, the intellectual property must be approved by the NCG. Consideration for funding is based on assessment of the following:

  • Commercial potential
  • Technical merit
  • Patent protection
  • Likelihood of achieving objectives with the resources provided
  • Ability of the funded studies to add significant value to the technology and/or to significantly improve its attractiveness for licensing or investment

Click here for information about IP and Licensing through the NCG.

For more information, contact:

Erli Chen, Ph.D.
University of Pennsylvania
Director, Nanotechnology Commercialization Group
chen@ctt.upenn.edu
(215) 898-9272

NTI: Signs of Success

NTI research programs have been extremely successful at publishing in peer-reviewed journals, resulting in more than 820 articles.

In addition, NTI researchers have been awarded more than 200 federal grants totaling more than $150 million.